NYSE:MIR

Mirion Announces First Quarter 2024 Financial Results and Reaffirms Full Year Guidance

Retrieved on: 
Tuesday, April 30, 2024
Research, Other Defense, Energy, Nuclear, Radiology, Health, Science, Defense, Oncology, Acquisition, Adjustment, MIR, Class, EPS, Growth, Internet service provider

“The first quarter was a solid start for Mirion in 2024,” stated Thomas Logan, Mirion’s Chief Executive Officer.

Key Points: 
  • “The first quarter was a solid start for Mirion in 2024,” stated Thomas Logan, Mirion’s Chief Executive Officer.
  • “Revenue growth was in-line with our expectations, led by a strong quarter from our Technologies segment.
  • Participants may access the call by dialing 1-844-826-3035 or 1-412-317-5195, and requesting to join the Mirion Technologies, Inc. earnings call.
  • An archived replay of the call and an accompanying presentation will also be available on the Investors section of the Mirion website at https://ir.mirion.com/ .

Mirion Announces Redemption of Public Warrants

Retrieved on: 
Thursday, April 18, 2024
Health, Defense, Energy, Government Technology, Radiology, Nuclear, Transfer, Sale, Common, MIR, Security (finance), Form S-3, Warrant, Exercise, Election, Form, Common stock, State Street, Redemption, Attention

Under the Warrant Agreement, Mirion is entitled to redeem its public warrants at a redemption price of $0.10 per warrant if the last sale price of the Common Stock equals or exceeds $10.00 per share on the trading day before the Company issues the notice of redemption (the “Stock Price Condition”), among other conditions.

Key Points: 
  • Under the Warrant Agreement, Mirion is entitled to redeem its public warrants at a redemption price of $0.10 per warrant if the last sale price of the Common Stock equals or exceeds $10.00 per share on the trading day before the Company issues the notice of redemption (the “Stock Price Condition”), among other conditions.
  • The stock price condition was satisfied on April 17, 2024, the day before the Notice of Redemption is being sent to warrant holders.
  • Warrant holders may continue to exercise their warrants to purchase shares of Common Stock until immediately before 5:00 p.m. New York City time on the Redemption Date.
  • The warrants are listed on the NYSE under the ticker symbol “MIR WS.” Any outstanding Mirion public warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable, except to receive the Redemption Price or as otherwise described in the Notice of Redemption.

Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024

Retrieved on: 
Wednesday, April 17, 2024
Engineering, Chemicals, Plastics, Manufacturing, Other Science, Research, Other Manufacturing, Science, MIR, News

Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024.

Key Points: 
  • Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024.
  • Following the news release, the company will host a conference call the next day, Wednesday, May 1, 2024, at 9:00 am ET to discuss the results.
  • Participants may access the call by dialing 1-844-826-3035 or 1-412-317-5195, and requesting to join the Mirion Technologies, Inc. earnings call.
  • An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/ .

Mirion to Participate in SHARE Series Fireside Chat on Monday, February 26, 2024

Retrieved on: 
Thursday, February 22, 2024
Research, Other Health, General Health, Other Defense, Radiology, Nuclear, Energy, Defense, Health Technology, Science, Military, Health, Other Science, SHARE, Webcast, MIR

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe.

Key Points: 
  • Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe.
  • The event will begin at 9:00 AM ET on Monday, February 26, 2024 and will feature an online portal for investors to submit questions to ask during the event.
  • The presentation will be webcast live at https://www.openexchange.tv/monday-management-update-february-26th/mirio... or may be accessed via our IR website at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section.
  • An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.

Mirion to Present at B. Riley Securities’ Radiopharma Day

Retrieved on: 
Thursday, February 22, 2024
Research, Clinical Trials, Health Technology, Biotechnology, Other Health, Health, General Health, Other Science, Science, MIR

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.

Key Points: 

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.

Mirion Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Guidance

Retrieved on: 
Tuesday, February 13, 2024
Manufacturing, Science, Other Science, Research, Chemicals, Plastics, Class, Acquisition, EPS, Webcast, MIR, Internet service provider

We delivered record revenue and adjusted EBITDA, and substantially improved cash generation and leverage,” stated Thomas Logan, Mirion’s Chief Executive Officer.

Key Points: 
  • We delivered record revenue and adjusted EBITDA, and substantially improved cash generation and leverage,” stated Thomas Logan, Mirion’s Chief Executive Officer.
  • “Looking at our fourth quarter results, both business segments generated organic growth against tough comparisons from the same period last year.
  • Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call.
  • An archived replay of the call and an accompanying webcast will also be available on the Investors section of the Mirion website at https://ir.mirion.com/ .

Mirion to Present at Citi’s 2024 Global Industrial Tech and Mobility Conference

Retrieved on: 
Monday, February 12, 2024
Radiology, Health Technology, Health, Medical Devices, Webcast, MIR, Conference

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL.

Key Points: 
  • Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL.
  • The presentation will begin at 1:50 PM ET on Wednesday, February 21, 2024.
  • The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section.
  • An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.

Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2023

Retrieved on: 
Wednesday, January 31, 2024
Radiology, Health Technology, Health, News, MIR

Mirion (NYSE: MIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024.

Key Points: 
  • Mirion (NYSE: MIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024.
  • Following the news release, the company will host a conference call the next day, Wednesday, February 14, 2024, at 10:00 am ET to discuss the results.
  • Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call.
  • An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/ .

Mirion Technologies Signs Agreement with TerraPower for Molten Chloride Reactor Experiment

Retrieved on: 
Thursday, November 16, 2023
Research, General Health, Other Energy, Nuclear, Sustainability, Alternative Energy, Energy, Environment, Science, Green Technology, Climate Change, Health, Other Science, TerraPower, NYSE, Climate change, Radiation, Senior, MCFR, MIR, Partnership, Idaho National Laboratory, Growth, Uranium mining, Southern Company

Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor.

Key Points: 
  • Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor.
  • This collaboration reinforces TerraPower and Mirion’s commitment to fostering sustainable, low-carbon energy solutions that address climate change and support a net-zero future.
  • The MCRE will inform the design, licensing and operation of TerraPower’s Molten Chloride Fast Reactor (MCFR) – an innovative reactor technology that could provide low-cost, clean energy at scale.
  • “Throughout the process of bringing the Molten Chloride Fast Reactor to market, we have found that working with a diverse supply chain strengthens our ability to deliver a cutting-edge technology,” said Jeff Latkowski, Senior Vice President for the Molten Chloride Fast Reactor.

Mirion Launches Philanthropic Partnership with RAD-AID International

Retrieved on: 
Wednesday, November 1, 2023
Research, Philanthropy, Training, Radiology, Health, Other Philanthropy, Other Science, Science, Education, DMC, NYSE, Therapy, MD, MIR, ATS, Partnership, Hospital, Radiation, CT, Developing country, Nuclear medicine, Medical imaging, Medical device

Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world.

Key Points: 
  • Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world.
  • As part of the partnership launch, Mirion made an in-kind donation to RAD-AID’s Medical Physics Program supporting healthcare efforts in Guyana, Grenada, Botswana, Morocco, Nigeria and Kenya.
  • By aligning with RAD-AID, Mirion aims to extend its impact beyond technological advancements and actively contribute to improving quality healthcare access and outcomes for vulnerable populations.
  • We look forward to leveraging our collective strengths across Mirion Technologies and Mirion Medical to support RAD-AID’s mission by empowering healthcare providers with the tools they need to save lives and improve patient outcomes.”